Completed NA INTERVENTIONAL 1-arm NCT02765191

MR-Evaluation of Renal Function In Septic Patients (MERSEP)

Sponsor: Uppsala University

Conditions Acute Kidney Injury COVID-19 Sepsis, Severe

Interventions Plasma expansion with Ringer's Acetate

Updated 11 times since 2017 Last updated: Dec 3, 2021 Started: Dec 7, 2016 Primary completion: May 10, 2021 Completion: Aug 10, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Acute Kidney Injury and COVID-19, this trial is completed. The trial is conducted by Uppsala University and has accumulated 11 data snapshots since 2016. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2022 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Dec 2021 — Jan 2022 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Nov 2021 — Dec 2021 [monthly]

Recruiting NA

▶ Show 6 earlier versions

Jan 2021 — Nov 2021 [monthly]

Recruiting NA
Jul 2020 — Jan 2021 [monthly]

Recruiting NA
Jun 2020 — Jul 2020 [monthly]

Recruiting NA
May 2019 — Jun 2020 [monthly]

Recruiting NA
Jun 2018 — May 2019 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Uppsala University

Data source: Uppsala University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Uppsala, Sweden